Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yumi Yoshii"'
Autor:
Sho Yoshimatsu, Kazuya Edamura, Yumi Yoshii, Aozora Iguchi, Hirotaka Kondo, Hisashi Shibuya, Tsukika Sato, Seiji Shiozawa, Hideyuki Okano
Publikováno v:
Stem Cell Research, Vol 53, Iss , Pp 102375- (2021)
We previously reported the non-viral derivation of transgene-free induced pluripotent stem cells (iPSCs) from somatic fibroblasts of a female beagle dog using an optimized induction medium and integration-free episomal vectors. Here, we report novel
Externí odkaz:
https://doaj.org/article/fc2a5e338510425c8aa2ffbd9c48749e
Publikováno v:
Life, Vol 11, Iss 8, p 796 (2021)
Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019. Because CG
Externí odkaz:
https://doaj.org/article/0b6cbe686e4c43dc9520dfe384558f5b
Autor:
Nobuhiro Yamakawa, Masahiro Umeda, Yumi Yoshii, Kenji Mitsudo, Makoto Noguchi, Jingo Kusukawa, Akira Katakura, Hideki Nakayama, Masashi Sasaki, Tadahide Noguchi, Michihiro Ueda, Hiroki Bukawa, Kazuhiro Yagihara, Akihisa Horie, Akihiro Miyazaki, Daichi Chikazu, Kei Tomihara, Katsuaki Mishima, Mitsunobu Otsuru, Seiji Asoda, Shigeyoshi Fujiwara, Yoshio Ohyama, Hiroshi Kurita, Hitoshi Kawamata, Masayuki Fukuda, Yukari Shintani, Takanori Kobayashi, Takahiro Kanno, Ichiro Oh‐iwa, Kenji Kawano, Yoshio Yamashita, Wataru Kobayashi, Yoichi Ohiro, Katsuhiro Uzawa, Yoshihide Ota, Tadaaki Kirita
Publikováno v:
Oral diseases.
Immunotherapy with nivolumab for patients with recurrent/metastatic oral squamous cell carcinoma has not been evaluated. Here, we aimed to examine the efficacy, safety, and prognostic factors of nivolumab in these patients.This multicentre retrospect
Publikováno v:
International Journal of Hematology. 112:764-772
Immune thrombotic thrombocytopenic purpura (iTTP) is caused by ADAMTS13 deficiency due to anti-ADAMTS13 autoantibodies. Rituximab, an anti-CD20 monoclonal antibody, is often used to suppress these autoantibodies. This retrospective study, conducted i
Autor:
Hirokazu Uemura, Akihisa Tanaka, Yumi Yoshii, Ichiro Ota, Ari Nishimura, Chihiro Morimoto, Tadashi Kitahara, Takashi Masui
Publikováno v:
Mol Clin Oncol
Multiple endocrine neoplasia (MEN) with medullary thyroid carcinoma (MTC) is associated with rearranged during transfection (RET) mutations. The authors encountered four cases of MTC-related MEN type 2B (MEN2B) with RET codon M918T mutation in one fa
Publikováno v:
Life
Life, Vol 11, Iss 796, p 796 (2021)
Life, Vol 11, Iss 796, p 796 (2021)
Next-generation sequencing-based comprehensive genome profiling (CGP) testing, OncoGuide NCC Oncopanel System, and FoundationOne CDx Cancer Genomic Profile have been covered by the Japanese national health insurance system since June 2019. Because CG
Autor:
Ayami Isonishi, Yumi Yoshii, Masanori Matsumoto, Charles L. Bennett, Yoshihiro Fujimura, Norio Kurumatani
Publikováno v:
Transfusion. 57:2045-2053
BACKGROUND Platelet (PLT) transfusions are probably harmful in patients with acquired idiopathic thrombotic thrombocytopenic purpura (aTTP). Introduction of a rapid assay for ADAMTS13 activity should reduce the time to definite diagnosis of aTTP, red
Autor:
Kazuya Edamura, Hideyuki Okano, Sho Yoshimatsu, Aozora Iguchi, Tsukika Sato, Hisashi Shibuya, Yumi Yoshii, Seiji Shiozawa, Hirotaka Kondo
Publikováno v:
Stem Cell Research, Vol 53, Iss, Pp 102375-(2021)
We previously reported the non-viral derivation of transgene-free induced pluripotent stem cells (iPSCs) from somatic fibroblasts of a female beagle dog using an optimized induction medium and integration-free episomal vectors. Here, we report novel
Autor:
Fumihiro Terasaki, Hajime Morita, Mio Ezura, Yoko Fujisawa, Hirotoshi Iihara, Naoto T. Ueno, Yoko Ichinari, Yumi Yoshii, Yoichi Osato, Sanae Nakajima, Manabu Futamura, Natsumi Matsumoto, Hisashi Suyama, Chihiro Kondoh, Mitsuki Kariya, Mutsumi Yamagami, Shigehira Saji
Publikováno v:
Annals of Oncology. 30:vi128-vi129
Background Promoting team-based cancer care is required. J-TOP (Japan TeamOncology Program) is consisted of multidisciplinary medical staff and we regularly hold workshop (WS) to realize high-performance team in which the hospital and community are l
Autor:
Yuko Tsuboguchi, Haruko Daga, Yumi Yoshii, Kohei Akiyoshi, Shinya Tokunaga, Shunsuke Okazaki, Hitoshi Goto, Shinya Ueda, Kazuyoshi Fukai, Masataka Shimozono, Yuki Nakatani
Publikováno v:
Annals of Oncology. 30:vi124-vi125
Background Choroidal melanoma with metastasis is known to have a poor prognosis with no established standard therapy. Recently there are some case reports that combination therapy of IPI and NIVO is effective, but with high incidence of immune-relate